AGP Executive Report
Last update: 12 minutes agoRegulation Watch: Massachusetts Cannabis Control Commission says most THC potency label checks on flower products were within range, but noncompliant items will be flagged and stopped from further sales. Retail Expansion: NatureMed opened its third Kentucky medical cannabis dispensary in Murray, aiming to cut travel time for patients and offering flower, edibles, and vaporizers. Clinical & Safety: A CDC update attributes a sharp rise in ER visits for cannabis hyperemesis syndrome to a new dedicated diagnosis code (introduced Oct. 1, 2025), not necessarily a true outbreak. Medical Evidence: UK registry data reports sustained improvements for endometriosis patients using cannabis-based medicinal products, including reduced pain and lower opioid use. Policy & Access: Georgia medical cannabis enrollment jumped after lawmakers expanded the program in May, adding more qualifying conditions and allowing botanical cannabis and higher-THC products. Research Signals: A new study links cannabis use with fewer premature heartbeats on use days in regular users, suggesting a potential heart rhythm effect worth watching. Enforcement: Nigeria customs seized cannabis sativa worth about N2.09bn, while other drug actions in Malaysia highlighted large multi-drug seizures and asset forfeitures.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.